B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMA8

MOLECULAR TARGET

proteasome 20S subunit alpha 8

UniProt: Q8TAA3NCBI Gene: 1434712 compounds

PSMA8 (proteasome 20S subunit alpha 8) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMA8

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.7114
2Reserpine1.614

About PSMA8 as a Drug Target

PSMA8 (proteasome 20S subunit alpha 8) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PSMA8 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMA8 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.